260 studies found for:    Open Studies | "Kidney Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting AMG 172 First in Human Study in Patients With Kidney Cancer
Conditions: Renal Cell Adenocarcinoma;   Clear Cell Renal Carcinoma;   Clear Cell Renal Cell Carcinoma;   Renal Cell Carcinoma
Intervention: Drug: AMG 172
22 Recruiting A Prospective Pilot Study Evaluating Renal Lesions Through Contrast-enhanced Ultrasound (US) in Patients With Renal Cancer and in Those With a Risk Factor for Renal Malignancy
Condition: Kidney Cancer
Interventions: Procedure: Contrast-enhanced Ultrasound;   Drug: Perflutren lipid
23 Unknown  Sunitinib Malate in Treating Patients With Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: sunitinib malate;   Other: laboratory biomarker analysis;   Other: pharmacological study
24 Unknown  Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: aldesleukin;   Biological: bevacizumab
25 Unknown  Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil
26 Unknown  Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: motexafin gadolinium;   Drug: sunitinib malate;   Genetic: comparative genomic hybridization;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: immunohistochemistry staining method;   Other: iodine I-124 girentuximab;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
27 Unknown  Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: sunitinib malate;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
28 Unknown  MRI in Predicting Response to Sunitinib Malate in Patients With Stage IV Kidney Cancer
Condition: Kidney Cancer
Interventions: Drug: sunitinib malate;   Genetic: mutation analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
29 Recruiting Autoantibody Blood Test in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method
30 Recruiting Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Interventions: Procedure: timing of surgery;   Genetic: gene expression analysis;   Other: biologic sample preservation procedure;   Other: laboratory biomarker analysis;   Procedure: therapeutic conventional surgery
31 Recruiting Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers
Conditions: Prostate Cancer;   Bladder Cancer;   Kidney Cancer
Intervention: Drug: Ferumoxytol
32 Unknown  Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: sunitinib malate;   Genetic: gene expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Genetic: western blotting;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
33 Recruiting Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: sunitinib malate
34 Recruiting Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery
Conditions: Kidney Cancer;   Liver Cancer
Interventions: Drug: hypoxia-activated prodrug TH-302;   Drug: sorafenib tosylate;   Genetic: protein analysis;   Other: laboratory biomarker analysis
35 Unknown  MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer
Condition: Kidney Cancer
Interventions: Biological: bevacizumab;   Biological: recombinant interferon alpha-2a
36 Not yet recruiting Immunotherapy Study for Metastatic Renal Cell Cancer
Conditions: Metastatic Renal Cell Carcinoma;   Metastatic Clear-cell Renal Cancer;   Recurrent Renal Cell Carcinoma;   Refractory Renal Cell Carcinoma;   Metastatic Kidney Cancer
Intervention: Biological: HyperAcute®-Renal (HAR) Immunotherapy
37 Recruiting Perfusion Scanning's for Kidney Tumors
Condition: Kidney Cancer
Intervention:
38 Unknown  Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Conditions: Bladder Cancer;   Brain and Central Nervous System Tumors;   Esophageal Cancer;   Intraocular Melanoma;   Kidney Cancer;   Lymphoma;   Melanoma (Skin);   Pancreatic Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
39 Recruiting Radiosurgery in Treating Patients With Kidney Tumors
Condition: Kidney Cancer
Interventions: Radiation: stereotactic radiosurgery;   Procedure: Renal Biopsy;   Procedure: Serum Blood Markers
40 Not yet recruiting A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell;   Kidney Diseases;   Kidney Neoplasms;   Urogenital Neoplasms;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms;   Neoplasms by Histologic Type;   Clear-cell Metastatic Renal Cell Carcinoma
Intervention: Drug: Combination of varlilumab and sunitinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years